Neurocognitive functioning in acute or early HIV infection

被引:35
|
作者
Moore, David J. [1 ,2 ]
Letendre, Scott L. [1 ,3 ]
Morris, Sheldon [3 ]
Umlauf, Anya [1 ]
Deutsch, Reena [1 ]
Smith, Davey M. [3 ]
Little, Susan [3 ]
Rooney, Alexandra [1 ]
Franklin, Donald R. [1 ]
Gouaux, Ben [1 ]
LeBlanc, Shannon [1 ]
Rosario, Debra [1 ]
Fennema-Notestine, Christine [1 ,2 ,4 ]
Heaton, Robert K. [1 ,2 ]
Ellis, Ronald J. [1 ,5 ]
Atkinson, J. Hampton [1 ,2 ]
Grant, Igor [1 ,2 ]
机构
[1] Univ Calif San Diego, HNRC, San Diego, CA 92103 USA
[2] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA
[3] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
[4] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA
[5] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA
关键词
HIV infection; HIV-associated neurocognitive disorders; Acute or early HIV; Primary HIV; NEUROPSYCHOLOGICAL IMPAIRMENT; RELIABILITY; DYNAMICS; VIREMIA; MARKERS; MEMORY; TIME;
D O I
10.1007/s13365-010-0009-y
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We examined neurocognitive functioning among persons with acute or early HIV infection (AEH) and hypothesized that the neurocognitive performance of AEH individuals would be intermediate between HIV seronegatives (HIV-) and those with chronic HIV infection. Comprehensive neurocognitive testing was accomplished with 39 AEH, 63 chronically HIV infected, and 38 HIV-participants. All AEH participants were HIV infected for less than 1 year. Average domain deficit scores were calculated in seven neurocognitive domains. HIV-, AEH, and chronically HIV infected groups were ranked from best (rank of 1) to worst (rank of 3) in each domain. All participants received detailed substance use, neuromedical, and psychiatric evaluations and HIV infected persons provided information on antiretroviral treatment and completed laboratory evaluations including plasma and CSF viral loads. A nonparametric test of ordered alternatives (Page test), and the appropriate nonparametric follow-up test, was used to evaluate level of neuropsychological (NP) functioning across and between groups. The median duration of infection for the AEH group was 16 weeks [interquartile range, IQR: 10.3-40.7] as compared to 4.9 years [2.8-11.1] in the chronic HIV group. A Page test using ranks of average scores in the seven neurocognitive domains showed a significant monotonic trend with the best neurocognitive functioning in the HIV- group (mean rank=1.43), intermediate neurocognitive functioning in the AEH group (mean rank=1.71), and the worst in the chronically HIV infected (mean rank=2.86; L statistic=94, p<0.01); however, post-hoc testing comparing neurocognitive impairment of each group against each of the other groups showed that the chronically infected group was significantly different from both the HIV- and AEH groups on neurocognitive performance; the AEH group was statistically indistinguishable from the HIV- group. Regression models among HIV infected participants were unable to identify significant predictors of neurocognitive performance. Neurocognitive functioning was worst among persons with chronic HIV infection. Although a significant monotonic trend existed and patterns of the data suggest the AEH individuals may fall intermediate to HIV- and chronic participants, we were not able to statistically confirm this hypothesis.
引用
收藏
页码:50 / 57
页数:8
相关论文
共 50 条
  • [41] Acute HIV Infection Mimicking Acute Sinusitis
    Akyildiz, Ozay
    Kurtaran, Behice
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2019, 24 (04): : 391 - 394
  • [42] Correlation between CD4/CD8 ratio and neurocognitive performance during early HIV infection
    Le, Leah T.
    Price, Richard W.
    Gisslen, Magnus
    Zetterberg, Henrik
    Emu, Brinda
    Fabre, Roxane
    Christian, Pradier
    Andersen, Signe
    Spudich, Serena
    Vassallo, Matteo
    HIV MEDICINE, 2023, 24 (04) : 442 - 452
  • [43] Applications and Limitations of Inflammatory Biomarkers for Studies on Neurocognitive Impairment in HIV Infection
    Edana Cassol
    Vikas Misra
    Susan Morgello
    Dana Gabuzda
    Journal of Neuroimmune Pharmacology, 2013, 8 : 1087 - 1097
  • [44] Applications and Limitations of Inflammatory Biomarkers for Studies on Neurocognitive Impairment in HIV Infection
    Cassol, Edana
    Misra, Vikas
    Morgello, Susan
    Gabuzda, Dana
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2013, 8 (05) : 1087 - 1097
  • [45] Intraindividual Variability in HIV Infection: Evidence for Greater Neurocognitive Dispersion in Older HIV Seropositive Adults
    Morgan, Erin E.
    Woods, Steven Paul
    Delano-Wood, Lisa
    Bondi, Mark W.
    Grant, Igor
    NEUROPSYCHOLOGY, 2011, 25 (05) : 645 - 654
  • [46] Facial Emotional Processing in HIV Infection: Relation to Neurocognitive and Neuropsychiatric Status
    Lane, Tammy A.
    Moore, Danielle M.
    Batchelor, Jennifer
    Brew, Bruce J.
    Cysique, Lucette A.
    NEUROPSYCHOLOGY, 2012, 26 (06) : 713 - 722
  • [47] Neurocognitive Consequences of HIV Infection in Older Adults: An Evaluation of the "Cortical" Hypothesis
    Scott, J. Cobb
    Woods, Steven Paul
    Carey, Catherine L.
    Weber, Erica
    Bondi, Mark W.
    Grant, Igor
    AIDS AND BEHAVIOR, 2011, 15 (06) : 1187 - 1196
  • [48] Aging and Neurocognitive Functioning in HIV-Infected Women: a Review of the Literature Involving the Women's Interagency HIV Study
    Vance, David E.
    Rubin, Leah H.
    Valcour, Victor
    Waldrop-Valverde, Drenna
    Maki, Pauline M.
    CURRENT HIV/AIDS REPORTS, 2016, 13 (06) : 399 - 411
  • [49] Aging and Neurocognitive Functioning in HIV-Infected Women: a Review of the Literature Involving the Women’s Interagency HIV Study
    David E. Vance
    Leah H. Rubin
    Victor Valcour
    Drenna Waldrop-Valverde
    Pauline M. Maki
    Current HIV/AIDS Reports, 2016, 13 : 399 - 411
  • [50] Drug Abuse and Hepatitis C Infection as Comorbid Features of HIV Associated Neurocognitive Disorder: Neurocognitive and Neuroimaging Features
    Martin-Thormeyer, Eileen M.
    Paul, Robert H.
    NEUROPSYCHOLOGY REVIEW, 2009, 19 (02) : 215 - 231